Mucoid Pseudomonas aeruginosa , TNF- α , and IL-1 β , but Not IL-6, Induce Human β -Defensin-2 in Respiratory Epithelia
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Cultured lung epithelial cells release antibacterial activity upon contact with Pseudomonas aeruginosa (PA), which is impaired in cystic fibrosis (CF). In order to identify the factors responsible for killing PA by a biochemical approach, we purified antimicrobial activity from supernatants of the A549 lung epithelial cell line, previously stimulated with PA bacteria, by subsequent high performance liquid chromatography. NH(2)-terminal sequencing of a major bactericidal compound revealed it to be identical with human beta-defensin-2 (hBD-2). A mucoid phenotype of PA, but not two nonmucoid PA strains, high concentrations (> 10 microg/ml) of PA lipopolysaccharide, tumor necrosis factor alpha, and interleukin (IL)-1beta, but not IL-6, dose-dependently induced hBD-2 messenger RNA in cultured normal bronchial, tracheal, as well as normal and CF-derived nasal epithelial cells. Genomic analysis of hBD-2 revealed a promoter region containing several putative transcription factor binding sites, including nuclear factor (NF) kappaB, activator protein (AP)-1, AP-2, and NF-IL-6, known to be involved in the regulation of inflammatory responses. Thus, hBD-2 represents a major inducible antimicrobial factor released by airway epithelial cells either on contact with mucoid PA or by endogenously produced primary cytokines. Therefore, it might be important in lung infections caused by mucoid PA, including those seen in patients with CF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schägger, H., & von Jagow, G. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90587-2 · Cited by 11,444
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Peptide Antibiotics and Their Role in Innate Immunity
Boman, H. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.61 · Cited by 1,665
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (1997) · Nature · doi:10.1038/43088 · Cited by 1,363
Self-citationHuman β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis
Goldman, M. J., Anderson, G. M., Stolzenberg, E. D., Kari, U. P., Zasloff, M., & Wilson, J. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81895-4 · Cited by 1,080
Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid
Smith, J. J., Travis, S. M., Greenberg, E. P., & Welsh, M. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81099-5 · Cited by 1,039
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 914
Triglia, T., Peterson, M. G., & Kemp, D. J. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.16.8186 · Cited by 809
Production of β-defensins by human airway epithelia
Singh, P. K., Jia, H. P., Wiles, K., Hesselberth, J., Liu, L., Conway, B.-A. D., Greenberg, E. P., Valore, E. V., Welsh, M. J., Ganz, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14961 · Cited by 579
Cited by
Antimicrobial peptides of multicellular organisms
Zasloff, M. (2002) · Nature · doi:10.1038/415389a · Cited by 8,457
Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008557200 · Cited by 1,311
Self-citationProperties of the amniotic membrane for potential use in tissue engineering
Department of Nanomedicine and Tissue Engineering, S. B. M. U., Niknejad, H., Peirovi, H., Jorjani, M., Ahmadiani, A., Ghanavi, J., & Seifalian, A. (2008) · European Cells and Materials · doi:10.22203/ecm.v015a07 · Cited by 823
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Saliva – the defender of the oral cavity
Amerongen, A. N., & Veerman, E. (2002) · Oral Diseases · doi:10.1034/j.1601-0825.2002.1o816.x · Cited by 760
Innate immunity in the lung: how epithelial cells fight against respiratory pathogens
Bals, R., & Hiemstra, P. S. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00098803 · Cited by 595
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572
Antimicrobial peptides: General overview and clinical implications in human health and disease
Guaní-Guerra, E., Santos-Mendoza, T., Lugo-Reyes, S. O., & Terán, L. M. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.12.004 · Cited by 549
Epithelial antimicrobial peptides in host defense against infection
Bals, R. (2000) · Respiratory Research · doi:10.1186/rr25 · Cited by 498
Wehkamp, J., Harder, J., Wehkamp, K., Meissner, B. W.-V., Schlee, M., Enders, C., Sonnenborn, U., Nuding, S., Bengmark, S., Fellermann, K., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5750-5758.2004 · Cited by 474
Self-citationInnate Immunity in the Respiratory Epithelium
Parker, D., & Prince, A. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0011rt · Cited by 456
Lai, Y., Cogen, A. L., Radek, K. A., Park, H. J., MacLeod, D. T., Leichtle, A., Ryan, A. F., Di Nardo, A., & Gallo, R. L. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.123 · Cited by 446
RNase 7, a Novel Innate Immune Defense Antimicrobial Protein of Healthy Human Skin
Harder, J., & Schröder, J.-M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207587200 · Cited by 425
Self-citationKao, C.-Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., & Wu, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3482 · Cited by 424
“Inductions of hBD-2 by IL-1 , IL-1 , and TNF- treatment are consistent with previous reports (17, 18, 41).”
ResultChronic rhinosinusitis pathogenesis
Stevens, W. W., Lee, R. J., Schleimer, R. P., & Cohen, N. A. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.009 · Cited by 388
Molecular Pathogenesis of Klebsiella Pneumoniae
Li, B., Zhao, Y., Liu, C., Chen, Z., & Zhou, D. (2014) · Future Microbiology · doi:10.2217/fmb.14.48 · Cited by 364
Reassessing the Host Defense Peptide Landscape
Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00043 · Cited by 359
The human beta-defensin-3, an antibacterial peptide with multiple biological functions
Dhople, V., Krukemeyer, A., & Ramamoorthy, A. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.007 · Cited by 355
Antimicrobial Peptides: Properties and Applicability
Hof, W. V. T., Veerman, E. C. I., Helmerhorst, E. J., & Amerongen, A. V. N. (2001) · Biological Chemistry · doi:10.1515/bc.2001.072 · Cited by 354
Schibli, D. J., Hunter, H. N., Aseyev, V., Starner, T. D., Wiencek, J. M., McCray, P. B., Tack, B. F., & Vogel, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108830200 · Cited by 347
NOD2/CARD15 Mediates Induction of the Antimicrobial Peptide Human Beta-defensin-2
Voss, E., Wehkamp, J., Wehkamp, K., Stange, E. F., Schröder, J. M., & Harder, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511044200 · Cited by 344
Self-citationMartin, T. R., & Frevert, C. W. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200508-090js · Cited by 341
Uehara, A., Fujimoto, Y., Fukase, K., & Takada, H. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2007.02.007 · Cited by 330
Liu, A. Y., Destoumieux, D., Wong, A. V., Park, C. H., Valore, E. V., Liu, L., & Ganz, T. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01651.x · Cited by 323
Antimicrobial Peptides: Current Status and Therapeutic Potential
Koczulla, A. R., & Bals, R. (2003) · Drugs · doi:10.2165/00003495-200363040-00005 · Cited by 306
Human β-Defensin 2 and 3 and Their Mouse Orthologs Induce Chemotaxis through Interaction with CCR2
Röhrl, J., Yang, D., Oppenheim, J. J., & Hehlgans, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903984 · Cited by 296
Alcayaga-Miranda, F., Cuenca, J., & Khoury, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00339 · Cited by 296
Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral Microorganisms
Joly, S., Maze, C., McCray, P. B., & Guthmiller, J. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1024-1029.2004 · Cited by 291
Contoversies in Experimental Dermatology
(2002) · Experimental Dermatology · doi:10.1034/j.1600-0625.2002.00112.x · Cited by 288
Hertz, C. J., Wu, Q., Porter, E. M., Zhang, Y. J., Weismüller, K.-H., Godowski, P. J., Ganz, T., Randell, S. H., & Modlin, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6820 · Cited by 285
Wanke, I., Steffen, H., Christ, C., Krismer, B., Götz, F., Peschel, A., Schaller, M., & Schittek, B. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.328 · Cited by 284
Vermaelen, K., & Pauwels, R. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1384so · Cited by 283
Sousa, A., & Pereira, M. (2014) · Pathogens · doi:10.3390/pathogens3030680 · Cited by 279
Hazlett, L., & Wu, M. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1022-4 · Cited by 270
β-Defensins in Lung Host Defense
Schutte, B. C., & McCray, P. B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.134340 · Cited by 258
Antimicrobial skin peptides and proteins
Schröder, J. M., & Harder, J. (2006) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-005-5364-0 · Cited by 253
Self-citationProud, D., Sanders, S. P., & Wiehler, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4637 · Cited by 154
“Because bacterial LPS, at concentrations of 10 g/ml, has been reported to induce HBD-2 expression (29), viral preparations were assayed for LPS.”
BackgroundMethodDuits, L. A., Nibbering, P. H., Strijen, E., Vos, J. B., Mannesse-Lazeroms, S. P. G., Sterkenburg, M. A. J. A., & Hiemstra, P. S. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00106-8 · Cited by 135
Mineshiba, J., Myokai, F., Mineshiba, F., Matsuura, K., Nishimura, F., & Takashiba, S. (2005) · FEMS Immunology & Medical Microbiology · doi:10.1016/j.femsim.2005.01.008 · Cited by 37
Metadata
- Authors
- Harder, J., Meyer-Hoffert, U., Teran, L. M., Schwichtenberg, L., Bartels, J., Maune, S., & Schröder, J.-M.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-06-01
- Volume
- 22
- Issue
- 6
- Pages
- 714-721
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2093412162
- Cited by
- 414
- References
- 38
- FWCI
- 18.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.